As described above, our recent study demonstrated that overexpression of CTLA-4 in T cells inhibited atherosclerosis development in Apoe−/− mice by downregulating the CD80 and CD86 expression on DCs and limiting the CD80/CD86–CD28-dependent activation of Teffs [34]. The gene discussed is CTLA4; the disease is atherosclerosis.